SEARCH:   Advanced

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Hashimoto, S.-i. Articles by Matsushima, K. Search for Related Content PubMed PubMed Citation Articles by Hashimoto, S.-i. Articles by Matsushima, K. Related Collections Immunobiology Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  Blood, 15 September 2000, Vol. 96, No. 6, pp. 2206-2214 IMMUNOBIOLOGY Identification of genes specifically expressed in human activated and mature dendritic cells through serial analysis of gene expression Shin-ichi Hashimoto, Takuji Suzuki, Shigenori Nagai, Taro Yamashita, Nobuaki Toyoda, and Kouji Matsushima From the Department of Molecular Preventive Medicine and CREST, School of Medicine, University of Tokyo, Tokyo, Japan.     Abstract Top Abstract Introduction Materials and methods Results Discussion References Dendritic cells (DCs) are professional antigen-presenting cells in the immune system and can be generated in vitro from hematopoietic progenitor cells, DC precursors, and monocytes in peripheral blood. Serial analysis of gene expression (SAGE) was conducted in lipopolysaccharide (LPS)-stimulated mature and activated DCs (MADCs) derived from human blood monocytes. A total of 31 837 tag sequences from an MADC cDNA library represented 10 962 different genes, and these data were compared with SAGE data for monocyte-derived immature DCs (IMDCs). Many of the genes, such as germinal center kinase-related protein kinase, cystatin F, interferon (IFN)--inducible protein p27, EBI3, HEM45, actin-bundling protein, ELC, DC-LAMP, serine/threonine kinase 4, and several genes in expressed sequence tags, were differentially expressed in MADCs, and those encode proteins related to cell structure, antigen-processing enzymes, chemokines, and IFN-inducible proteins. The profile of MADCs was also compared with that of LPS-stimulated monocytes. The Epstein-Barr virus-induced gene 3 and IFN--inducible protein p27 are newly identified to be specifically and highly expressed in MADCs, but not in LPS-stimulated monocytes. The comprehensive identification of specific genes expressed in human IMDCs and MADCs should provide candidate genes to define heterogeneous subsets as well as the function and maturation stage of DCs. (Blood. 2000;96:2206-2214) © 2000 by The American Society of Hematology.     Introduction Top Abstract Introduction Materials and methods Results Discussion References Dendritic cells (DCs) play a pivotal role in the immune system by processing and presenting antigens to CD4+ naive T cells.1 DCs have also been reported to be involved in the direct induction of CD8+ cytotoxic T cells,2 immunoglobulin production by B cells,3 and T-cell tolerance.4,5 DCs, which are found in virtually every tissue and fluid, are mostly immature DCs expressing a chemokine receptor, CCR1 or CCR6, and are able to capture antigens. Once activated by inflammatory stimuli, DCs mature and start to express a chemokine receptor, CCR7, and also produce chemokines that recruit various types of leukocytes, including immature DCs at the inflammatory site. These mature and activated DCs (MADCs) are consequently recruited via the lymphatics to the T-cell-rich areas of secondary lymphoid organs to stimulate CD4+ naive T cells6-8 by SLC produced in the lymphatic endothelium and high endothelial venules. DCs undergo a series of events leading to irreversible maturation and ending with apoptotic cell death.9 During their migration, DCs undergo further changes of phenotype and function, including loss of antigen uptake and processing and increase of accessory function. DC maturation can be influenced by a variety of factors, notably microbial and inflammatory mediators. Whole bacteria, the gram-negative microbial cell-wall component lipopolysaccharide (LPS),10 monocyte-conditioned medium,11 and cytokines such as interleukin (IL)-1 and tumor necrosis factor- (TNF-) all stimulate DC maturation. Ceramide, which is induced by maturation signals, can shut down antigen capture by the DCs.12 Mature DCs express high levels of the NF-kB family of transcriptional control proteins,13,14 which regulate the expression of many genes encoding immune and inflammatory proteins. During maturation of DCs, the expression of CD83, CD80, CD86, and CD49 is kept, but that of CD1a is reduced.10,15 DCs in lymphoid and nonlymphoid organs vary in their surface markers and functions and therefore have different names, such as Langerhans cells in the epidermis; interdigitating DCs in lymph nodes; interstitial DCs in the heart, lung, kidney, and intestine; and thymic DCs in the thymus. DCs are thought to belong to a lineage distinct from monocytes and macrophages. However, it has been reported that macrophages and DCs share a common progenitor.16,17 Human DCs have been generated from CD34+ precursor cells isolated from cord blood18 and bone marrow19 in the presence of granulocyte-macrophage colony-stimulating factor (GM-CSF) and TNF-. Moreover, blood monocytes cultured with GM-CSF and IL-4 differentiate into nonadherent CD1a+CD14low cells with morphologic and functional characteristics of DCs.20,21 However, the process of differentiation from monocytes to DCs has not yet been explored systematically. To clarify this point, we previously performed serial analysis of gene expression (SAGE) in immature DCs (IMDCs) derived from human blood monocytes.22 Many of the genes that were differentially expressed in IMDCs were identified to be genes encoding proteins related to cell structure, cell motility, and chemokines. In this study, to further understand the characteristics of DC differentiation, we have applied the SAGE method to human MADCs. The SAGE method has proved to be a powerful means for the quantitative cataloging and comparison of expressed genes in the cells or tissues from various physiologic, developmental, and pathologic states.23-27     Materials and methods Top Abstract Introduction Materials and methods Results Discussion References Preparation of cells Peripheral blood mononuclear cells (PBMCs) were isolated from venous blood drawn from normal healthy volunteers at the Tokyo Metropolitan Red Cross Blood Center.22 Briefly, PBMCs were isolated by centrifugation on a Ficoll-Metrizoate density gradient (d = 1.077, Lymphoprep; Nycomed, Oslo, Norway) and suspended in RPMI 1640 medium containing 7.5% heat-inactivated fetal calf serum (FCS; GIBCO/LIFE Technologies, Tokyo, Japan), 100 µg/mL streptomycin, and 100 U/mL penicillin G. The FCS contained 3 pg of LPS per milliliter as assessed by a Limulus amebocyte lysate. PBMCs were incubated with anti-CD14 monoclonal antibody (mAb) bound with microbeads, and monocytes were isolated by passing the PBMCs through a magnetic cell separation system (MACS; Miltenyi Biotec, Germany) with column type VR. These cell suspensions were then aliquoted into plastic tissue culture plates and incubated for 30 minutes at 37°C in 5% CO2 to obtain the highly purified cells. More than 99% of the cells were judged to be monocytes by morphology, by positive staining for CD14 (LeuM3; Becton Dickinson, San Jose, CA) in flow cytometric analysis, and by nonspecific esterase staining. Phenotyping with monoclonal antibodies The expression of leukocyte cell surface markers and cytoplasmic antigens was assessed. The cells were sequentially incubated with optimal concentrations of biotinylated anti-CD86 (2331; PharMingen, San Diego, CA) and anti-CD1a mAbs (HI 149; PharMingen), followed by fluorescein isothiocyanate (FITC)-labeled streptavidin and by phycoerythrin (PE)-conjugated goat anti-mouse IgG, respectively, or directly stained with FITC-labeled anti-HLA-DR (4C3; PharMingen), mouse anti-CD80 (MAB104; Coulter, Fullerton, CA), CD83 (HB15a; Coulter), and PE-labeled anti-CD14 (M5E; PharMingen) mAbs. To block nonspecific FcR-mediated binding of mAbs, cells were incubated for 60 minutes at 4°C with normal goat serum (Cedarlane Laboratories Ltd, Hornby, Ontario, Canada) before staining. For all experiments, irrelevant control mAbs of the same IgG isotype and second step controls were included. Stained cells were fixed with 1% paraformaldehyde (Sigma), and analyses were performed using the EPICS XL (Beckman Coulter, Hialeah, FL). SAGE protocol mRNAs of MADCs were purified from a mixture of total RNA from 6 donors. Monocytes were incubated with IL-4 (100 U/mL; Ono Pharmaceutical Co, Ltd, Japan) or GM-CSF (500 U/mL; Kirin Brewery Co, Ltd, Japan) in RPMI 1640 medium containing 7.5% FCS in 5% CO2 at 37°C for 7 days, then incubated with 100 µg/mL of LPS for 2 days. Total RNA from these cells was isolated by direct lysis in RNAzol B (Cinna/Biotex Laboratories, USA). Poly(A)+ RNA was isolated using the FastTrac mRNA purification kit (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. SAGE was done as described.23,24,28 SAGE libraries were generated using 1.5 µg poly(A)+ RNA, which was converted to cDNA with a BRL synthesis kit (GIBCO BRL, Rockville, MD) with the inclusion of primer biotin-labeled 5'-T18-3'. The cDNA was cleaved with the restriction enzyme NlaIII, and the 3'-terminal cDNA fragments were bound to streptavidin-coated magnetic beads (Dynal, Oslo, Norway). After ligation to oligonucleotides containing recognition sites for BsmF1, the linked cDNAs were released from the beads by digestion with BsmF1. The released tags were ligated to one another, concatenated, and cloned into the SphI site of pZero 1.0 (Invitrogen). Colonies were screened with polymerase chain reaction (PCR) using M13 forward and M13 reverse primers. PCR products containing inserts of longer than 400 bp were sequenced with the Big Dye terminator kit and analyzed with a 377 ABI automated 96-lane sequencer (Perkin-Elmer, Branchburg, NJ). All electropherograms were reanalyzed by visual inspection to check for ambiguous bases and to correct misreads. SAGE was performed on mRNA from MADCs and LPS-stimulated monocytes. Sequence files were analyzed with the SAGE software,28 the National Center for Biotechnology Information (NCBI) SAGE database (http://www.ncbi.nlm.nih.gov/SAGE/), and NCBI's sequence search tool (Advanced BLAST search, http://www.ncbi.nlm.nih.gov/BLAST/). After elimination of linker sequences and the repeated ditags, a total of 31 837 tag sequences from MADCs were analyzed. Reverse transcriptase (RT)-PCR Total RNAs (200 ng) were prepared by the use of RNAzol B. The RNA was reverse-transcribed in 50 µL of 10 mmol/L Tris-HCl (pH 8.3), 6.5 mmol/L MgCl2, 50 mmol/L KCl, 10 mmol/L dithiothreitol, 1 mmol/L of each dNTP, 2 µmol/L random hexamer, and 2.4 U/µL of Moloney murine leukemia virus reverse transcriptase for 1 hour at 42°C. The cDNA, corresponding to 40 ng of total RNA, was boiled for 3 minutes and quenched on ice before amplification by PCR. The conditions for PCR were as follows: in a 50-µL reaction, 0.15 µmol/L of each primer; 1.25 µmol/L of each dGTP, dATP, dCTP, and dTTP (Toyobo); 50 mmol/L KCl; 10 mmol/L Tris-HCl, pH 8.3; 0.15 mmol/L MgCl2; and AmpliTaq (Perkin-Elmer). The cycle number of PCR for each gene is shown in parentheses and primers used were as follows: CCR7 (28): sense 5'-TCCTTCTCATCAGCAAGCTGTC-3', antisense 5'-GAGGCAGCCCAGGTCCTTGAAG-3'; actin-bundling protein (25): sense 5'-ATGGACCTGTCTGCCAATCAG-3', antisense 5'-CTTTGATGTTGTAGGCGCCA-3'; interferon (IFN)-inducible protein 27 (30): sense 5'-TCTGCTCTCACCTCATCAGCA-3', antisense 5'-CCTGGCATGGTTCTCTTCTCTG-3'; HEM45 (28): sense 5'-GGTGCTGTGCTGTACGACAAGT-3', antisense 5'-CGGATTCTCTGGGAGATTTGAT-3'; EBI3 (30): sense 5'-TGTTCTCCATGGCTCCCTACGT-3', antisense 5'-TACTTGCCCAGGCTCATTGTGG-3'; DC-LAMP (30): sense 5'-GGCCCTAGCTTAGCCCCTTATT-3', antisense 5'-CTCCGAGGTGAAAAAACCGA-3'; cystatin F (28): sense 5'-TTCCCAGGACCTTAACTCACGT-3', antisense 5'-GGTGTTTGTCATGGCTGTGGT-3'; CD23 (28): sense 5'-GGAGGAACTTCGAGCTGAACA-3', antisense 5'-AGTTCCGAAGGCCAATCCA-3'; lysosomal acid lipase (28): sense 5'-TCTTCCCCAGAGTGCGTTTTt-3', antisense 5'-CATGGAACACCAAGTTGGTGAT-3'; CD11b (28): sense 5'-TGTGAAAGGGCTCTGCTTCCT-3', antisense 5'-TCTTAAAGGCATTCTTTCGGGC-3'; IgGFcR (28): sense 5'-CTTTTCCGTGCTTACCTGCAG-3', antisense 5'-AAATCAGCATCCTGGGCCT-3'; factor XIII (28): sense 5'-ATTGGCCCTAGAAACTGCCCT-3', antisense 5'-TGGACTTTTGCTTGGCCAGA-3'; MacMARCKS (40): sense 5'-CCACGTGAAAAGCAATGGAGA-3', antisense 5'-TTCTGAGGCTGCACTAGCCTCT-3'; IL-12 p35 (40): sense 5'-CCTTCACCACTCCCAAAACCT-3', antisense 5'-TGAAATTCAGGGCCTGCATC-3'; IL-12 p40 (30): sense 5'-GGATGCCCCTGGAGAAATGG-3', antisense 5'-CTCCCAGCTGACCTCCACCT-3'; and adenylyl cyclase-associated protein (CAP) (28): sense 5'-GCACTGTTCGCGCAGATTAA-3', antisense 5'-A CAATGCCCACCACGTCAT-3'. Reaction mixtures were incubated in a Perkin-Elmer DNA Thermal Cycler (denaturation, 60 seconds at 94°C; annealing, 60 seconds at 58°C; extension, 120 seconds at 72°C). Statistical analysis Statistical significance between samples was calculated as described previously.29 To analyze the correlation coefficients between the different libraries, 58 540, 31 837, 31 837, 57 560, 55 856, and 57 463 tags from IMDCs, MADCs, LPS-stimulated monocytes (LPS-Mo), monocytes (Mo), macrophage colony-stimulating factor (M-CSF)-induced macrophages, and GM-CSF-induced macrophages,30 respectively, were normalized to 31 837, and then all pairwise Pearson correlation coefficients for each library-to-library comparison were calculated using all normalized gene expression measurements.     Results Top Abstract Introduction Materials and methods Results Discussion References Surface phenotype of LPS-stimulated MADCs To identify genes specifically expressed in MADCs, we generated SAGE libraries from human MADCs. Peripheral blood CD14+ monocytes were cultured with GM-CSF plus IL-4 for 5 days and then stimulated with LPS for 2 days. Under these culture conditions, the cells differentiated into nonadherent CD14, CD1a/+, CD80+, CD83+, CD86+, CD40high, and HLA-DRhigh cells with the dendritic morphology of MADCs (Figure 1), which validates the phenotype of MADCs. View larger version (35K): [in this window] [in a new window]   Figure 1. Surface phenotype of human blood monocyte-derived DCs stimulated by LPS (MADCs). Human monocytes were cultured in RPMI 1640 medium plus 7.5% FCS in the presence of GM-CSF (500 U/mL) and IL-4 (100 U/mL) for 5 days and then stimulated with LPS for 2 days. After culture, the cells were washed and then stained with various antibodies as described in "Materials and methods." The data are shown as histograms depicting the number of cells exhibiting various fluorescence intensities. The dotted lines represent MADCs stained with specific antibodies, the solid histograms represent IMDCs stained with specific antibodies, and the solid lines represent isotype-matched control. Results are representative of 3 independent experiments. SAGE tag abundance in MADCs A total of 31 837 tag sequences from the MADC library allowed the identification of 10 962 different genes. Next, the expressed genes were searched through the GeneBank database to identify individual genes. Table 1 shows the top 50 transcripts in MADCs. The most frequently expressed gene in human MADCs was identified to be TARC (expression frequency, 2.62%), followed by ferritin H-chain gene (2.57%) and 2-microglobulin gene (2.06%). Overall, the genes expressed abundantly in the MADC library mostly consist of genes encoding major histocompatibility complex (MHC) class I and class II, chemokines, molecules related to protein synthesis, and cytoskeleton proteins. More information is available on the internet at http://www.prevent.m.u-tokyo.ac.jp/SAGE.html/.                                View this table: [in this window] [in a new window]   Table 1. Transcript profile in LPS-stimulated mature DCs (MADCs) Comparison of expression patterns in MADCs IMDC SAGE libraries were generated from human monocytes cultured in GM-CSF plus IL-4 plus TNF- for 5 days.22 Under these culture conditions, the cells differentiated into nonadherent CD1a+, CD80low/, CD86low/, HLA-DR+, CD40+, and CD83 cells with the dendritic morphology of IMDCs (Figure 1). The 58 540 and 31 837 tag sequences from the IMDC and MADC libraries, respectively, were normalized to 31 837, and then comparison of the expressed genes between IMDCs and MADCs was performed. The expression levels of most of the transcripts in these cells were similar (Figure 2). However, 225 transcripts were found to be statistically different (P < .01) between these types of cells. Expression levels of 95 of 225 genes were decreased in MADCs as compared with those in IMDCs. Conversely, 130 transcripts were expressed at higher levels in MADCs than in IMDCs. Table 2 shows the top 50 increased transcripts in MADCs as compared with IMDCs. The most frequently increased transcript was identified to be germinal center kinase-related protein kinase (70-fold), followed by CCR7 (67-fold), cystatin F (66-fold), and so on. The transcripts increased in MADCs mainly consisted of genes encoding chemokines such as RANTES, ELC, PARC, MDC, and TARC; a chemokine receptor CCR7; enzymes such as germinal center kinase-related protein kinase, metallothionein 2A, and serine/threonine kinase 4; and IFN-inducible proteins such as IFN-stimulated protein 15 kd, IFN--inducible protein p27, IFN--inducible protein p78, HEM45 (IFN-stimulated gene 20 kd), IFN--inducible protein (clone IFI-6-16), and IFN-inducible protein 17. Table 2 compares the SAGE data for MADCs with those for monocytes, M-CSF-induced macrophages, and GM-CSF-induced macrophages. These data demonstrate that many of the genes, which are highly expressed in MADCs, are low in monocytes and macrophages. View larger version (23K): [in this window] [in a new window]   Figure 2. Comparison of gene expression frequency in IMDCs and MADCs. A semilogarithmic plot reveals that 44 tags were decreased more than 10-fold in MADCs compared with IMDCs, whereas 71 tags were increased more than 10-fold in MADCs compared with IMDCs. Each number of tags was normalized to 31 837. The relative expression of each transcript was determined by dividing the number of tags observed in IMDCs or MADCs, as indicated. To avoid division by 0, a tag value of 1 for any tag that was not detectable in one sample was used. These ratios are plotted on the abscissa. The number of genes displaying each ratio is plotted on the ordinate.                                View this table: [in this window] [in a new window]   Table 2. Increased transcripts in MADCs Table 3 shows the top 50 transcripts that are decreased in MADCs. The transcripts decreased in MADCs mainly consisted of genes encoding enzymes such as lipase A, 1-antichymotrypsin, glucose-6-phosphatase, and acid phosphatase type 5; and surface marker proteins such as CD52, CD11b, factor XIII, and CD23.                                View this table: [in this window] [in a new window]   Table 3. Decreased transcripts in MADCs RT-PCR of genes selected in the SAGE analysis Although our data represent the average gene expression in cells obtained from 6 healthy donors, there could be differences in gene expression among individual donor-derived cells. To address this question, we arbitrarily selected 10 differently expressed genes and evaluated them in 4 donor-derived samples by RT-PCR (Figure 3), and compared the expression of each transcript with the SAGE data. CAP was expressed almost equally in all cell types (IMDCs, tag number 11; MADCs, 9), but actin-bundling protein (IMDCs, 4; MADCs, 148), IFN-inducible protein (IMDCs, 0; MADCs, 46), HEM45 (IMDCs, 0; MADCs, 21), EBI3 (IMDCs, 0; MADCs, 31), and cystatin F (IMDCs, 1; MADCs, 66) were highly expressed in MADCs. On the other hand, CD23 (IMDCs, 11; MADCs, 1), lysosomal acid lipase (IMDCs, 68; MADCs, 0), CD11b (IMDCs, 23; MADCs, 0), IgGFcR (IMDCs, 9; MADCs, 1), and factor XIII (IMDCs, 16; MADCs, 0) were highly expressed in IMDCs. These results validate our SAGE data for IMDCs and MADCs and establish the general gene expression in these cells. View larger version (89K): [in this window] [in a new window]   Figure 3. RT-PCR analysis of genes expressed differently in IMDCs and MADCs. RT-PCR was performed on total RNA isolated from (1) IMDCs and (2) MADCs, as described in "Materials and methods." A, B, C, and D indicate different donors. Comparison of gene expression profile of MADCs with that of LPS-stimulated monocytes It is well known that LPS modulates the expression of numerous genes encoding proteins such as cytokines, chemokines, and transcriptional factors in monocytes. Thus, a comparison between MADCs and LPS-Mo (manuscript in preparation) was conducted to identify specific genes expressed only in MADCs. The 57 560 and 35 874 tag sequences from the Mo30 and LPS-Mo libraries, respectively, were normalized to 31 837 and were compared with the transcripts increased in MADCs (Table 2). The expression levels of RANTES (IMDCs, 0; MADCs, 42; LPS-Mo, 11; Mo, 0), IFN-stimulated protein 15 kd (IMDCs, 2; MADCs, 82; LPS-Mo, 48; Mo, 4), IFN-inducible protein P78 (IMDCs, 1; MADCs, 30; LPS-Mo, 11; Mo, 1), superoxide dismutase 2 (IMDCs, 0; MADCs, 26; LPS-Mo, 54; Mo, 4), activating transcription factor 4 (IMDCs, 1; MADCs, 20; LPS-Mo, 8; Mo, 11), HEM45 (IMDCs, 0; MADCs, 21; LPS-Mo, 7; Mo, 0), MDC (IMDCs, 18; MADCs, 336; LPS-Mo, 12; Mo, 0), IFN-inducible protein (IFI-6-16) (IMDCs, 7; MADCs, 106; LPS-Mo, 24; Mo, 14), and TARC (IMDCs, 68; MADCs, 831; LPS-Mo, 16; Mo, 0) were increased in LPS-stimulated DCs as well as in LPS-Mo, as compared with Mo (Table 2). On the other hand, the expression levels of genes encoding proteins such as cystatin C (IMDCs, 1; MADCs, 66; LPS-Mo, 0; Mo, 0), IFN--inducible protein p27 (IMDCs, 0; MADCs, 40; LPS-Mo, 0; Mo, 0), actin-bundling protein (IMDCs, 4; MADCs, 148; LPS-Mo, 0; Mo, 0), EBI3 (IMDCs, 0; MADCs, 31; LPS-Mo, 0; Mo, 0), ELC (IMDCs, 0; MADCs, 27; LPS-Mo, 0; Mo, 0), DC-LAMP (IMDCs, 1; MADCs, 25; LPS-Mo, 0; Mo, 0), MacMARCKS (IMDCs, 1; MADCs, 21; LPS-Mo, 0; Mo, 0), serine/threonine kinase 4 (IMDCs, 0; MADCs, 12; LPS-Mo, 0; Mo, 1), pim-2 oncogene (IMDCs, 1; MADCs, 40; LPS-Mo, 0; Mo, 1), and several genes in ESTs, were highly specific for MADCs. Time course of the induction of MADC-specific genes During DC activation and maturation, the expression of several genes has been described to be increased. For example, it is already known that CCR7 is highly expressed in activated DCs,15,31 and DCs activated by several stimuli can produce IL-12.32-34 Here, EBI3, IFN--inducible protein p27, and MacMARCKS were newly identified as the inducible genes during DC activation and maturation. The time course of the induction of these genes was analyzed together with that of the CCR7, DC-LAMP, and IL-12 (p35 and p40) genes (Figure 4). Although IMDCs barely expressed the genes for IFN--inducible protein, EBI3, CCR7, and MacMARCKS, the level of mRNAs of most of these genes sharply increased within 3 hours after the stimulation with LPS and reached a maximum at 24 hours. IL-12 p35 and p40 mRNAs were transiently induced from 3 hours to 12 hours. View larger version (79K): [in this window] [in a new window]   Figure 4. Kinetics of the induction of various mRNA expression by stimulating IMDCs with LPS. RT-PCR was performed on total RNA isolated from IMDCs cultured in the presence of GM-CSF and IL-4 for 5 days, followed by 0, 1, 3, 6, 12, 24, and 48 hours of activation with LPS (100 µg/mL). Correlation coefficients for all pairwise comparisons of libraries To estimate the extent of similarity between any 2 libraries (monocytes, GM-CSF-induced macrophages, M-CSF-induced macrophages, IMDCs, and MADCs), we calculated each bivariate correlation coefficient. The correlation coefficients for all comparisons are shown in Table 4. Pearson correlation coefficients between GM-CSF- and M-CSF-induced macrophage libraries showed a high similarity, at 0.938. However, the extent of similarity between any other 2 libraries ranged from 0.460 to 0.659.                                 View this table: [in this window] [in a new window]   Table 4. Correlation coefficients between the different libraries     Discussion Top Abstract Introduction Materials and methods Results Discussion References In this study, we performed SAGE for LPS-stimulated mature DCs to obtain insights on the molecular level into the differentiation from IMDCs to MADCs. Differential gene expression during DC maturation can be divided into 3 parts: a change of subcellular compartments to process antigens, a change of cell surface molecules to adhere to tissues and lymphocytes, and a change of molecules related to cell migration. The differential gene expression of the multiple subcellular compartments that correlate with different stages of DC maturation may be involved in the loading of peptides on class I and class II molecules. The increased gene expression of several subcellular compartments, including enzymes such as cystatin F (IMDCs, 1; MADCs, 66), germinal center kinase-related protein kinase (IMDCs, 3; MADCs, 210), metallothionein 2A (IMDCs, 1; MADCs, 47), protein kinase C substrate, MARCKS 80K-L (IMDCs, 1; MADCs, 39) and DC-LAMP (IMDCs, 1; MADCs, 25), was also observed (P < .001). In contrast, many of the genes such as lipase A (IMDCs, 68; MADCs, 0), cystatin B (IMDCs, 58; MADCs, 15), cathepsin B (IMDCs, 104; MADCs, 45), and cystatin C (IMDCs, 243; MADCs, 74) were down-regulated significantly (P < .01). These regulations of gene expression may be related to the capability of antigen processing of IMDCs and MADCs. Moreover, many of the genes encoding IFN-inducible proteins were found to be increased. It is known that IFNs increase the expression of MHC antigens. In mice with a targeted disruption of the IFN- gene, reduced expression of macrophage MHC class II antigens has been observed.35 Furthermore, in IFN signal protein-deficient mice, IRF-1/ mice, the expression of surface class I MHC is reduced.36 Therefore, the IFN-inducible proteins, which were found to be increased in MADCs, may be involved in the regulation of MHC class I and II. The expression of the genes encoding cell surface molecules, such as class I molecules (IMDCs, 43; MADCs, 172), 2-microglobulin (IMDCs, 143; MADCs, 655), and Landinin (IMDCs, 0; MADCs, 10), was up-regulated (P < .01). In contrast, expression levels of the genes for class II molecules (IMDCs, 373; MADCs, 64), CD74 (IMDCs, 533; MADCs, 272), CD52 (IMDCs, 56; MADCs, 2), factor XIII (IMDCs, 16; MADCs, 0), CD9 (IMDCs, 9; MADCs, 0), CD23 (IMDCs, 11; MADCs, 1), CD11b (IMDCs, 23; MADCs, 0), and GA733-1 (IMDCs, 10; MADCs, 0) were down-regulated significantly (P < .05). The change in the expression of these genes encoding proteins related to cell surface molecules might be involved in adhesion to tissues and cells or capturing antigens. It is well known that bacterial products such as LPS increase the synthesis of MHC class I and II molecules in DCs. However, our data showed the down-regulation of genes of MHC class II-related molecules in MADCs as compared with IMDCs. Because it has been reported that the class II molecules are quickly synthesized and the expression is shut off in a short time after the synthesis of the class I molecules,37 this may be the reason for the apparent discrepancy. Cell migration involves the coordinate activation of 2 classes of effector molecules, adhesion molecules and chemotactic factors.38 Many of the transcripts increased in MADCs consist of genes encoding chemokines such as TARC, MDC, RANTES, ELC, PARC, and a chemokine receptor CCR7 (Table 2). These results suggest that MADCs not only up-regulate the CCR7 to be recruited to secondary lymphoid organs to activate naive T lymphocytes as antigen-presenting cells, but also release chemotactic factors to attract memory-type Th1/Th2 polarized cells. In addition, these chemokines produced by MADCs at the inflammatory sites may also be involved in the recruitment of various types of leukocytes other than lymphocytes. It is well known that LPS induces various types of genes encoding cytokines, chemokines, and transcriptional factors in monocytes. Thus, comparison of the gene expression profiles between MADCs and LPS-stimulated monocytes is important to negate the possibility that the identified genes are merely LPS-inducible genes. The expression of the genes of RANTES, IFN-inducible protein (IFI-6-16), IFN-inducible protein P78, superoxide dismutase 2, HEM45, activating transcription factor 4, MDC, IFN--inducible protein, and TARC was increased in MADCs as well as in LPS-stimulated monocytes as compared with monocytes. On the other hand, the genes for cystatin C, IFN--inducible protein p27, actin-bundling protein, EBI3, ELC, DC-LAMP, PARC, MacMARCKS, and several genes in ESTs were expressed in MADCs but not in monocytes stimulated by LPS. DC-LAMP is a lysosomal protein involved in remodeling of specialized antigen-processing compartments and in MHC class II-restricted antigen presentation, and its gene expression is known to be up-regulated in mature DCs induced by CD40L, TNF-, and LPS.39 Therefore, DC-LAMP has been used as a DC maturation marker as CD83.40 Our results agree with these findings. Actin-bundling protein is known to be involved in the organization of the actin cytoskeleton in cytoplasmic extensions of nerve growth cones.41 Recently, it has been reported that actin-bundling protein plays a key role in forming dendritic processes in Langerhans cell maturation.42 Our data suggest that actin-bundling protein may also be involved in dendrite formation in monocyte-derived mature DCs, as in Langerhans cells. Interestingly, EBI3 has not been found to be expressed in any other types of cells or tissues available in the SAGE database so far, which suggests that EBI3 is a highly specific gene expressed in MADCs. Furthermore, we checked whether mature DCs induced by other stimuli express EBI3. TNF- and anti-CD40 antibody also induced EBI3 mRNA expression in mature DCs, as LPS did (data not shown). These results indicate that mature DCs generally express EBI3. EBI3 is a soluble hematopoietic component related to the p40 subunit of IL-12 and has been reported to be expressed in Epstein-Barr virus-transformed B lymphocytes, tonsil, and spleen.43 Our results suggest that EBI3 may be expressed in mature DCs in tonsil and spleen. On the other hand, EBI3 forms a heterodimer with p35,44 and IL-12 production by DCs favors the differentiation of Th0 cells into Th1 cells.33,34,45,46 Therefore, the EBI3/p35 heterodimer is likely to be an important regulator for polarization into Th1 cells by mature DCs. On the other hand, kinetic analysis of IL-12 and EBI3 showed different expression patterns (Figure 4), suggesting that EBI3 gene expression is regulated independently from IL-12 gene expression. Establishment of the biologic role of EBI3 seems important. In conclusion, SAGE allows both quantitative and simultaneous analysis of large numbers of transcripts. We investigated a total of 183 811 tags derived from 57 560, 58 540, 31 837, and 35 874 tags from monocytes, IMDCs, LPS-stimulated monocytes, and MADCs, respectively, and this allowed identification of 39 211 independent gene transcripts. The identification of the genes selectively expressed in human MADCs, including many novel genes, should provide molecular information to define different sets of resting and activated DCs and contribute to further understanding of the biologic function of DCs in the host defense system, and may also be useful for diagnosing or monitoring human diseases in which DCs play a role.     Acknowledgments We are very grateful to Drs Victor E. Velculescu, Lin Zhang, Wei Zhou, Bert Vogelstein, and Kenneth W. Kinzler for their help in SAGE analysis.     Footnotes Submitted March 27, 2000; accepted May 19, 2000. The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734. Reprints: Kouji Matsushima, Department of Molecular Preventive Medicine, School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan; e-mail: koujim{at}m.u-tokyo.ac.jp.     References Top Abstract Introduction Materials and methods Results Discussion References 1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245-252[Medline] [Order article via Infotrieve]. 2. Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature. 1998;392:86-89[Medline] [Order article via Infotrieve]. 3. Sornasse T, Flamand V, De Becker G, et al. Antigen-pulsed dendritic cells can efficiently induce an antibody response in vivo. J Exp Med. 1992;175:15-21[Abstract/Free Full Text]. 4. Zhong G, Sousa CR, Germain RN. Antigen-unspecific B cells and lymphoid dendritic cells both show extensive surface expression of processed antigen-major histocompatibility complex class II complexes after soluble protein exposure in vivo or in vitro. J Exp Med. 1997;186:673-682[Abstract/Free Full Text]. 5. Inaba K, Turley S, Yamaide F, et al. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J Exp Med. 1998;188:2163-2173[Abstract/Free Full Text]. 6. MacPherson GG, Jenkins CD, Stein MJ, Edwards C. Endotoxin-mediated dendritic cell release from the intestine: characterization of released dendritic cells and TNF dependence. J Immunol. 1995;154:1317-1322[Abstract]. 7. Roake JA, Rao AS, Morris PJ, Larsen CP, Hankins DF, Austyn JM. Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J Exp Med. 1995;181:2237-2247[Abstract/Free Full Text]. 8. De Smedt T, Pajak B, Muraille E, et al. Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J Exp Med. 1996;184:1413-1424[Abstract/Free Full Text]. 9. Winzler C, Rovere P, Rescigno M, et al. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J Exp Med. 1997;185:317-328[Abstract/Free Full Text]. 10. Palucka KA, Taquet N, Sanchez-Chapuis F, Gluckman JC. Dendritic cells as the terminal stage of monocyte differentiation. J Immunol. 1998;160:4587-4595[Abstract/Free Full Text]. 11. Reddy A, Sapp M, Feldman M, Subklewe M, Bhardwaj N. A monocyte conditioned medium is more effective than defined cytokines in mediating the terminal maturation of human dendritic cells. Blood. 1997;90:3640-3646[Abstract/Free Full Text]. 12. Sallusto F, Nicolo C, De Maria R, Corinti S, Testi R. Ceramide inhibits antigen uptake and presentation by dendritic cells. J Exp Med. 1996;184:2411-2416[Abstract/Free Full Text]. 13. Neumann M, Fries H-W, Scheicher C, et al. Differential expression of Rel/NF-kB and octamer factor is a hallmark of the generation and maturation of dendritic cells. Blood. 2000;95:277-285[Abstract/Free Full Text]. 14. Burkly L, Hession C, Ogata L, et al. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature. 1995;373:531-536[Medline] [Order article via Infotrieve]. 15. Yanagihara S, Komura E, Nagafune J, Watarai H, Yamaguchi Y. EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation. J Immunol. 1998;161:3096-3102[Abstract/Free Full Text]. 16. Reid C, Fryer P, Clifford C, Kirk A, Tikerpae J, Knight S. Identification of hematopoietic progenitors of macrophages and dendritic Langerhans cells (DL-CFU) in human bone marrow and peripheral blood. Blood. 1990;76:1139-1149[Abstract/Free Full Text]. 17. Randolph GJ, Inaba K, Robbiani DF, Steinman RM, Muller WA. Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity. 1999;11:753-761[Medline] [Order article via Infotrieve]. 18. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature. 1992;360:258-261[Medline] [Order article via Infotrieve]. 19. Reid C, Stackpoole A, Meager A, Tikerpae J. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow. J Immunol. 1992;149:2681-2688[Abstract]. 20. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 1994;179:1109-1118[Abstract/Free Full Text]. 21. Akagawa KS, Takasuka N, Nozaki Y, et al. Generation of CD1+RelB+ dendritic cells and tartrate-resistant acid phosphatase-positive osteoclast-like multinucleated giant cells from human monocytes. Blood. 1996;88:4029-4039[Abstract/Free Full Text]. 22. Hashimoto S, Suzuki T, Dong HY, Nagai S, Yamazaki N, Matsushima K. Serial analysis of gene expression in human monocyte-derived dendritic cells. Blood. 1999;94:845-852[Abstract/Free Full Text]. 23. Velculescu VE, Zhang L, Zhou W, et al. Characterization of the yeast transcriptome. Cell. 1997;88:243-251[Medline] [Order article via Infotrieve]. 24. Zhang L, Zhou W, Velculescu VE, et al. Gene expression profiles in normal and cancer cells. Science. 1997;276:1268-1272[Abstract/Free Full Text]. 25. Velculescu VE, Madden SL, Zhang L, et al. Analysis of human transcriptomes [letter]. Nat Genet. 1999;23:387-388[Medline] [Order article via Infotrieve]. 26. Lal A, Lash AE, Altschul SF, et al. A public database for gene expression in human cancers. Cancer Res. 1999;59:5403-5407[Abstract/Free Full Text]. 27. He TC, Sparks AB, Rago C, et al. Identification of c-MYC as a target of the APC pathway. Science. 1998;281:1509-1512[Abstract/Free Full Text]. 28. Velculescu VE, Zhang L, Vogelstein B, Kinzler KW. Serial analysis of gene expression. Science. 1995;270:484-487[Abstract/Free Full Text]. 29. Madden SL, Galella EA, Zhu J, Bertelsen AH, Beaudry GA. SAGE transcript profiles for p53-dependent growth regulation. Oncogene. 1997;15:1079-1085[Medline] [Order article via Infotrieve]. 30. Hashimoto S, Suzuki T, Dong HY, Yamazaki N, Matsushima K. Serial analysis of gene expression in human monocytes and macrophages. Blood. 1999;94:837-844[Abstract/Free Full Text]. 31. Dieu MC, Vanbervliet B, Vicari A, et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med. 1998;188:373-386[Abstract/Free Full Text]. 32. Macatonia SE, Hosken NA, Litton M, et al. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol. 1995;154:5071-5079[Abstract]. 33. Hilkens CM, Kalinski P, de Boer M, Kapsenberg ML. Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype. Blood. 1997;90:1920-1926[Abstract/Free Full Text]. 34. Kalinski P, Schuitemaker JH, Hilkens CM, Wierenga EA, Kapsenberg ML. Final maturation of dendritic cells is associated with impaired responsiveness to IFN-gamma and to bacterial IL-12 inducers: decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells. J Immunol. 1999;162:3231-3236[Abstract/Free Full Text]. 35. Dalton DK, Pitts-Meek S, Keshay S, Figari IS, Bradley A, Stewart TA. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science. 1993;259:1739-1742[Abstract/Free Full Text]. 36. White L, Wright K, Felix N, et al. Regulation of LMP2 and TAP1 genes by IRF-1 explains the paucity of CD8+ T cells in IRF-1/ mice. Immunity. 1996;5:365-376[Medline] [Order article via Infotrieve]. 37. Rescigno M, Citterio S, Thery C, et al. Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells. Proc Natl Acad Sci U S A. 1998;95:5229-5234[Abstract/Free Full Text]. 38. Springer T. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994;76:301-314[Medline] [Order article via Infotrieve]. 39. de Saint-Vis B, Vincent J, Vandenabeele S, et al. A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment. Immunity. 1998;9:325-336[Medline] [Order article via Infotrieve]. 40. Bell D, Chomarat P, Broyles D, et al. In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J Exp Med. 1999;190:1417-1426[Abstract/Free Full Text]. 41. Sasaki Y, Hayashi K, Shirao T, Ishikawa R, Kohama K. Inhibition by drebrin of the actin-bundling activity of brain fascin, a protein localized in filopodia of growth cones. J Neurochem. 1996;66:980-988[Medline] [Order article via Infotrieve]. 42. Ross R, Ross XL, Schwing J, Langin T, Reske-Kunz AB. The actin-bundling protein fascin is involved in the formation of dendritic processes in maturing epidermal Langerhans cells. J Immunol. 1998;160:3776-3782[Abstract/Free Full Text]. 43. Devergne O, Hummel M, Koeppen H, et al. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J Virol. 1996;70:1143-1153[Abstract]. 44. Devergne O, Birkenbach M, Kieff E. Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc Natl Acad Sci U S A. 1997;94:12041-12046[Abstract/Free Full Text]. 45. Verhasselt V, Buelens C, Willems F, De Groote D, Haeffner-Cavaillon N, Goldman M. Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway. J Immunol. 1997;158:2919-2925[Abstract]. 46. Sousa CR, Hieny S, Scharton-Kersten T, et al. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J Exp Med. 1997;186:1819-1829[Abstract/Free Full Text]. © 2000 by The American Society of Hematology.   CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: N. Sekiguchi, S. Kawauchi, T. Furuya, N. Inaba, K. Matsuda, S. Ando, M. Ogasawara, H. Aburatani, H. Kameda, K. Amano, et al. Messenger ribonucleic acid expression profile in peripheral blood cells from RA patients following treatment with an anti-TNF-{alpha} monoclonal antibody, infliximab Rheumatology, June 1, 2008; 47(6): 780 - 788. [Abstract] [Full Text] [PDF] S. Szameit, K. Vierlinger, L. Farmer, H. Tuschl, and C. Noehammer Microarray-Based In Vitro Test System for the Discrimination of Contact Allergens and Irritants: Identification of Potential Marker Genes Clin. Chem., March 1, 2008; 54(3): 525 - 533. [Abstract] [Full Text] [PDF] C. Dong, A. M. Janas, J.-H. Wang, W. J. Olson, and L. Wu Characterization of Human Immunodeficiency Virus Type 1 Replication in Immature and Mature Dendritic Cells Reveals Dissociable cis- and trans-Infection J. Virol., October 15, 2007; 81(20): 11352 - 11362. [Abstract] [Full Text] [PDF] V. M. Ripoll, K. M. Irvine, T. Ravasi, M. J. Sweet, and D. A. Hume Gpnmb Is Induced in Macrophages by IFN-{gamma} and Lipopolysaccharide and Acts as a Feedback Regulator of Proinflammatory Responses J. Immunol., May 15, 2007; 178(10): 6557 - 6566. [Abstract] [Full Text] [PDF] U. A. Hasan, C. Caux, I. Perrot, A.-C. Doffin, C. Menetrier-Caux, G. Trinchieri, M. Tommasino, and J. Vlach Cell proliferation and survival induced by Toll-like receptors is antagonized by type I IFNs PNAS, May 8, 2007; 104(19): 8047 - 8052. [Abstract] [Full Text] [PDF] J. B. Vos, N. A. Datson, K. F. Rabe, and P. S. Hiemstra Exploring host-pathogen interactions at the epithelial surface: application of transcriptomics in lung biology Am J Physiol Lung Cell Mol Physiol, February 1, 2007; 292(2): L367 - L377. [Abstract] [Full Text] [PDF] J. Li, D. K. Pritchard, X. Wang, D. R. Park, R. E. Bumgarner, S. M. Schwartz, and W. C. Liles cDNA microarray analysis reveals fundamental differences in the expression profiles of primary human monocytes, monocyte-derived macrophages, and alveolar macrophages J. Leukoc. Biol., January 1, 2007; 81(1): 328 - 335. [Abstract] [Full Text] [PDF] A. W. Schuttelkopf, G. Hamilton, C. Watts, and D. M. F. van Aalten Structural Basis of Reduction-dependent Activation of Human Cystatin F J. Biol. Chem., June 16, 2006; 281(24): 16570 - 16575. [Abstract] [Full Text] [PDF] A. Rivollier, L. Perrin-Cocon, S. Luche, H. Diemer, J.-M. Strub, D. Hanau, A. van Dorsselaer, V. Lotteau, C. Rabourdin-Combe, T. Rabilloud, et al. High Expression of Antioxidant Proteins in Dendritic Cells: Possible Implications in Atherosclerosis Mol. Cell. Proteomics, April 1, 2006; 5(4): 726 - 736. [Abstract] [Full Text] [PDF] I. I. Slukvin, M. A. Vodyanik, J. A. Thomson, M. E. Gumenyuk, and K.-D. Choi Directed Differentiation of Human Embryonic Stem Cells into Functional Dendritic Cells through the Myeloid Pathway. J. Immunol., March 1, 2006; 176(5): 2924 - 2932. [Abstract] [Full Text] [PDF] S. Iwamoto, M. Ishida, K. Takahashi, K. Takeda, and A. Miyazaki Lipopolysaccharide stimulation converts vigorously washed dendritic cells (DCs) to nonexhausted DCs expressing CD70 and evoking long-lasting type 1 T cell responses J. Leukoc. Biol., August 1, 2005; 78(2): 383 - 392. [Abstract] [Full Text] [PDF] T. Zavasnik-Bergant, U. Repnik, A. Schweiger, R. Romih, M. Jeras, V. Turk, and J. Kos Differentiation- and maturation-dependent content, localization, and secretion of cystatin C in human dendritic cells J. Leukoc. Biol., July 1, 2005; 78(1): 122 - 134. [Abstract] [Full Text] [PDF] P. A. Efron, H. Tsujimoto, F. R. Bahjat, R. Ungaro, J. Debernardis, C. Tannahill, H. V. Baker, C. K. Edwards, and L. L. Moldawer Differential maturation of murine bone-marrow derived dendritic cells with lipopolysaccharide and tumor necrosis factor-{alpha} Innate Immunity, June 1, 2005; 11(3): 145 - 160. [Abstract] [PDF] S. Wirtz, C. Becker, M. C. Fantini, E. E. Nieuwenhuis, I. Tubbe, P. R. Galle, H.-J. Schild, M. Birkenbach, R. S. Blumberg, and M. F. Neurath EBV-Induced Gene 3 Transcription Is Induced by TLR Signaling in Primary Dendritic Cells via NF-{kappa}B Activation J. Immunol., March 1, 2005; 174(5): 2814 - 2824. [Abstract] [Full Text] [PDF] C. Beers, A. Burich, M. J. Kleijmeer, J. M. Griffith, P. Wong, and A. Y. Rudensky Cathepsin S Controls MHC Class II-Mediated Antigen Presentation by Epithelial Cells In Vivo J. Immunol., February 1, 2005; 174(3): 1205 - 1212. [Abstract] [Full Text] [PDF] J. G. Maresh, H. Xu, N. Jiang, and R. V. Shohet In Vivo Transcriptional Response of Cardiac Endothelium to Lipopolysaccharide Arterioscler Thromb Vasc Biol, October 1, 2004; 24(10): 1836 - 1841. [Abstract] [Full Text] [PDF] S. Suzuki, K. Honma, T. Matsuyama, K. Suzuki, K. Toriyama, I. Akitoyo, K. Yamamoto, T. Suematsu, M. Nakamura, K. Yui, et al. From the Cover: Critical roles of interferon regulatory factor 4 in CD11bhighCD8{alpha}- dendritic cell development PNAS, June 15, 2004; 101(24): 8981 - 8986. [Abstract] [Full Text] [PDF] P. Perrier, F. O. Martinez, M. Locati, G. Bianchi, M. Nebuloni, G. Vago, F. Bazzoni, S. Sozzani, P. Allavena, and A. Mantovani Distinct Transcriptional Programs Activated by Interleukin-10 with or without Lipopolysaccharide in Dendritic Cells: Induction of the B Cell-Activating Chemokine, CXC Chemokine Ligand 13 J. Immunol., June 1, 2004; 172(11): 7031 - 7042. [Abstract] [Full Text] [PDF] A. Grolleau, D. E. Misek, R. Kuick, S. Hanash, and J. J. Mule Inducible Expression of Macrophage Receptor Marco by Dendritic Cells Following Phagocytic Uptake of Dead Cells Uncovered by Oligonucleotide Arrays J. Immunol., September 15, 2003; 171(6): 2879 - 2888. [Abstract] [Full Text] [PDF] H. L. Wilson and H. C. O'Neill Identification of differentially expressed genes representing dendritic cell precursors and their progeny Blood, September 1, 2003; 102(5): 1661 - 1669. [Abstract] [Full Text] [PDF] C. A. Wells, T. Ravasi, R. Sultana, K. Yagi, P. Carninci, H. Bono, G. Faulkner, Y. Okazaki, J. Quackenbush, D. A. Hume, et al. Continued Discovery of Transcriptional Units Expressed in Cells of the Mouse Mononuclear Phagocyte Lineage Genome Res., June 1, 2003; 13(6): 1360 - 1365. [Abstract] [Full Text] [PDF] S.-i. Hashimoto, S. Nagai, J. Sese, T. Suzuki, A. Obata, T. Sato, N. Toyoda, H.-Y. Dong, M. Kurachi, T. Nagahata, et al. Gene expression profile in human leukocytes Blood, May 1, 2003; 101(9): 3509 - 3513. [Abstract] [Full Text] [PDF] S.-R. Han, A. Momeni, K. Strach, P. Suriyaphol, D. Fenske, K. Paprotka, S. I. Hashimoto, M. Torzewski, S. Bhakdi, and M. Husmann Enzymatically Modified LDL Induces Cathepsin H in Human Monocytes: Potential Relevance in Early Atherogenesis Arterioscler Thromb Vasc Biol, April 1, 2003; 23(4): 661 - 667. [Abstract] [Full Text] [PDF] Y. K. Choi, B. A. Fallert, M. A. Murphey-Corb, and T. A. Reinhart Simian immunodeficiency virus dramatically alters expression of homeostatic chemokines and dendritic cell markers during infection in vivo Blood, March 1, 2003; 101(5): 1684 - 1691. [Abstract] [Full Text] [PDF] E. E. S. Nieuwenhuis, M. F. Neurath, N. Corazza, H. Iijima, J. Trgovcich, S. Wirtz, J. Glickman, D. Bailey, M. Yoshida, P. R. Galle, et al. Disruption of T helper 2-immune responses in Epstein-Barr virus-induced gene 3-deficient mice PNAS, December 24, 2002; 99(26): 16951 - 16956. [Abstract] [Full Text] [PDF] D.P. Dickinson SALIVARY (SD-TYPE) CYSTATINS: OVER ONE BILLION YEARS IN THE MAKING--BUT TO WHAT PURPOSE? Critical Reviews in Oral Biology & Medicine, November 1, 2002; 13(6): 485 - 508. [Abstract] [Full Text] [PDF] A. Obata-Onai, S.-i. Hashimoto, N. Onai, M. Kurachi, S. Nagai, K.-i. Shizuno, T. Nagahata, and K. Matsushima Comprehensive gene expression analysis of human NK cells and CD8+ T lymphocytes Int. Immunol., October 1, 2002; 14(10): 1085 - 1098. [Abstract] [Full Text] [PDF] J. H. Ahn, Y. Lee, C. Jeon, S.-J. Lee, B.-H. Lee, K. D. Choi, and Y.-S. Bae Identification of the genes differentially expressed in human dendritic cell subsets by cDNA subtraction and microarray analysis Blood, August 13, 2002; 100(5): 1742 - 1754. [Abstract] [Full Text] [PDF] E. Wang, L. D. Miller, G. A. Ohnmacht, S. Mocellin, A. Perez-Diez, D. Petersen, Y. Zhao, R. Simon, J. I. Powell, E. Asaki, et al. Prospective Molecular Profiling of Melanoma Metastases Suggests Classifiers of Immune Responsiveness Cancer Res., July 1, 2002; 62(13): 3581 - 3586. [Abstract] [Full Text] [PDF] D. Soulet and S. Rivest Perspective: How to Make Microarray, Serial Analysis of Gene Expression, and Proteomic Relevant to Day-to-Day Endocrine Problems and Physiological Systems Endocrinology, June 1, 2002; 143(6): 1995 - 2001. [Abstract] [Full Text] [PDF] N. Higashi, K. Fujioka, K. Denda-Nagai, S.-i. Hashimoto, S. Nagai, T. Sato, Y. Fujita, A. Morikawa, M. Tsuiji, M. Miyata-Takeuchi, et al. The Macrophage C-type Lectin Specific for Galactose/N-Acetylgalactosamine Is an Endocytic Receptor Expressed on Monocyte-derived Immature Dendritic Cells J. Biol. Chem., May 31, 2002; 277(23): 20686 - 20693. [Abstract] [Full Text] [PDF] M. Montoya, G. Schiavoni, F. Mattei, I. Gresser, F. Belardelli, P. Borrow, and D. F. Tough Type I interferons produced by dendritic cells promote their phenotypic and functional activation Blood, May 1, 2002; 99(9): 3263 - 3271. [Abstract] [Full Text] [PDF] M. Locati, U. Deuschle, M. L. Massardi, F. O. Martinez, M. Sironi, S. Sozzani, T. Bartfai, and A. Mantovani Analysis of the Gene Expression Profile Activated by the CC Chemokine Ligand 5/RANTES and by Lipopolysaccharide in Human Monocytes J. Immunol., April 1, 2002; 168(7): 3557 - 3562. [Abstract] [Full Text] [PDF] G. Ferlazzo, M. L. Tsang, L. Moretta, G. Melioli, R. M. Steinman, and C. Munz Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells J. Exp. Med., February 4, 2002; 195(3): 343 - 351. [Abstract] [Full Text] [PDF] J. Li, B. Schuler-Thurner, G. Schuler, C. Huber, and B. Seliger Bipartite regulation of different components of the MHC class I antigen-processing machinery during dendritic cell maturation Int. Immunol., December 1, 2001; 13(12): 1515 - 1523. [Abstract] [Full Text] [PDF] O. Devergne, A. Coulomb-L'Hermine, F. Capel, M. Moussa, and F. Capron Expression of Epstein-Barr Virus-Induced Gene 3, an Interleukin-12 p40-Related Molecule, throughout Human Pregnancy : Involvement of Syncytiotrophoblasts and Extravillous Trophoblasts Am. J. Pathol., November 1, 2001; 159(5): 1763 - 1776. [Abstract] [Full Text] [PDF] Y. T. Lee, L. D. Miller, A. N. Gubin, F. Makhlouf, U. Wojda, A. J. Barrett, E. T. Liu, and J. L. Miller Transcription patterning of uncoupled proliferation and differentiation in myelodysplastic bone marrow with erythroid-focused arrays Blood, September 15, 2001; 98(6): 1914 - 1921. [Abstract] [Full Text] [PDF] K. Polyak and G. J. Riggins Gene Discovery Using the Serial Analysis of Gene Expression Technique: Implications for Cancer Research J. Clin. Oncol., June 1, 2001; 19(11): 2948 - 2958. [Abstract] [Full Text] [PDF] This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Hashimoto, S.-i. Articles by Matsushima, K. Search for Related Content PubMed PubMed Citation Articles by Hashimoto, S.-i. Articles by Matsushima, K. Related Collections Immunobiology Social Bookmarking                   What's this?

	Copyright © 2000 by American Society of Hematology         Online ISSN: 1528-0020